List of articles with "ADC Therapeutics"

ADC Employee Grants

2026-02-02 21:20:34

Switzerland ADC Therapeutics ZYNLONTA Lausanne antibody drug conjugates

Investigation: ADC Therapeutics

2026-01-22 16:22:57

United States New York Pomerantz LLP ADC Therapeutics ZYNLONTA

Investigation of ADC Therapeutics

2026-01-15 16:15:02

USA New York Securities Fraud Pomerantz LLP ADC Therapeutics

ADC Therapeutics 2025 Estimates

2026-01-08 21:18:19

Switzerland ADC Therapeutics ZYNLONTA Lausanne LOTIS trials

Pomerantz Investigates ADC

2026-01-08 15:33:31

USA New York Pomerantz SEC Investigation ADC Therapeutics

ADC Therapeutics at J.P. Morgan

2026-01-08 12:21:59

Switzerland ADC Therapeutics ZYNLONTA Lausanne antibody drug conjugates

ADC Therapeutics Grant

2026-01-02 21:13:24

Switzerland ADC Therapeutics ZYNLONTA Lausanne antibody drug conjugates

Pomerantz Investigates ADC

2026-01-01 15:09:21

United States New York Securities Fraud Pomerantz LLP ADC Therapeutics

Oncology Platforms Rise

2025-12-19 13:00:49

USA Vancouver ADC Therapeutics GT Biopharma Sutro Biopharma

Pomerantz Investigates ADC

2025-12-11 15:51:40

USA New York Pomerantz LLP ADC Therapeutics ADCT

ADC Therapeutics Inducement Grants

2025-12-01 21:25:22

Switzerland ADC Therapeutics ZYNLONTA Lausanne antibody drug conjugates

ADC Q3 2025 Update

2025-11-10 12:41:34

Switzerland ADC Therapeutics ZYNLONTA Lausanne LOTIS trials

ADC Therapeutics in November

2025-10-27 11:29:11

Switzerland ADC Therapeutics ZYNLONTA Lausanne antibody drug conjugates

ADC Raises $60 Million

2025-10-13 11:43:40

Switzerland ADC Therapeutics ZYNLONTA Lausanne Private Placement

ADC's New Grants

2025-10-01 20:29:27

Switzerland ADC Therapeutics ZYNLONTA Lausanne antibody drug conjugates

ADC Employee Grants

2025-09-02 20:18:42

Switzerland ADC Therapeutics ZYNLONTA Lausanne antibody drug conjugates

ADC Therapeutics at Cantor 2025

2025-08-27 11:27:37

Switzerland ADC Therapeutics ZYNLONTA Lausanne antibody drug conjugates

ADC Therapeutics Q2 2025

2025-08-12 11:43:30

Switzerland ADC Therapeutics ZYNLONTA Lausanne glofitamab

ADC Therapeutics Grants

2025-08-01 20:11:24

Switzerland ADC Therapeutics ZYNLONTA Lausanne antibody drug conjugates

ADC Therapeutics Incentive

2025-07-01 20:10:33

stock options ADC Therapeutics ZYNLONTA

ZYNLONTA® Data at ICML

2025-06-16 11:24:24

Switzerland ADC Therapeutics Lausanne ZYNLONTA® Marginal Zone Lymphoma

ADC Therapeutics $100M Placement

2025-06-12 10:48:14

Switzerland ADC Therapeutics ZYNLONTA Lausanne Private Placement

ADC Grants Stock Options

2025-06-02 20:12:55

stock options Switzerland ADC Therapeutics ZYNLONTA Lausanne

ADC Therapeutics' Investor Events

2025-05-15 11:23:18

Switzerland ADC Therapeutics ZYNLONTA Lausanne Ameet Mallik

ADC Therapeutics Q1 2025

2025-05-14 13:12:10

Switzerland ADC Therapeutics ZYNLONTA Lausanne LOTIS-7

ADC Therapeutics at AACR 2025

2025-04-28 11:24:21

Cancer Research Switzerland ADC Therapeutics Lausanne ADCT-242

ADC Grants to New Recruits

2025-04-03 08:23:11

Switzerland ADC Therapeutics ZYNLONTA Lausanne antibody drug conjugates

ADC Therapeutics Q4 2024 Update

2025-03-27 11:37:40

Switzerland ADC Therapeutics ZYNLONTA Lausanne DLBCL

ADC Therapeutics at AACR

2025-03-26 08:28:41

Switzerland ADC Therapeutics Lausanne AACR 2025 antibody-drug conjugates

ADC Employee Induction

2025-02-03 21:20:54

Switzerland ADC Therapeutics ZYNLONTA Lausanne antibody drug conjugates

ADC's Employee Incentives

2025-01-02 21:18:10

stock options Switzerland ADC Therapeutics ZYNLONTA Lausanne

Phase 3 Trial of ZYNLONTA

2024-12-30 21:59:28

Switzerland ADC Therapeutics ZYNLONTA Lausanne DLBCL

LOTIS-7 Trial Insights

2024-12-11 12:32:17

Switzerland ADC Therapeutics ZYNLONTA Lausanne bispecific antibody

ZYNLONTA & Rituximab Findings

2024-12-09 12:43:01

Switzerland ADC Therapeutics ZYNLONTA Lausanne Rituximab

LOTIS-7 Data Update

2024-12-06 12:38:53

Switzerland ADC Therapeutics ZYNLONTA Lausanne glofitamab

New Stock Options for Employees

2024-12-02 21:34:28

Switzerland ADC Therapeutics ZYNLONTA Employee Stock Options Lausanne